Immunotherapy for stage 4 bladder cancer: what to know

Stage 4 bladder cancer has spread beyond its original site or to distant parts of the body. Immunotherapy uses medicines that alter immune signals, allowing immune cells to respond to cancer. It is a systemic treatment, meaning it can reach cancer in different locations, and it may be used alone or with chemotherapy depending on the clinical situation. Intravesical BCG therapy is a different treatment placed inside the bladder and is generally used for selected bladder-confined disease, not as a substitute for systemic care in widespread cancer.

Ask the team what tests confirm the diagnosis and extent, which may include cystoscopy, imaging or laboratory tests. Share your medicines, autoimmune conditions, organ problems and prior cancer treatments. Record pain, urinary changes, bowel symptoms, cough, breathing, rash, energy and appetite between appointments. Difficulty passing urine needs prompt medical advice, particularly if urine flow stops. Treatment can be adjusted when side effects or changes in the cancer call for a different approach. Bladder removal surgery may be discussed in selected situations, but it is not the same as immunotherapy.

Contact the cancer team quickly for new or worsening breathlessness, persistent cough, diarrhoea, severe abdominal pain, yellowing skin, reduced urine, confusion, a widespread rash or marked weakness. Seek urgent care for inability to pass urine, severe breathing difficulty, chest pain, fainting, sudden confusion or repeated vomiting. Do not wait for a routine infusion visit when a symptom is rapidly worsening.

Ask why immunotherapy is being recommended, whether chemotherapy is also suitable, how scans and symptoms will be used to assess the plan, and what treatment changes are possible. Clarify the infusion schedule, immune-related warning signs, after-hours contact and how urinary symptoms should be handled.